A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Participants With Acute Myelogenous Leukemia
Clinical trial NCT02287233 · COMPLETED
Trial details
- NCT number
- NCT02287233
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-31
- Primary completion
- 2021-08-10
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.